Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/27/2012 | CN102516374A Protein system for tetramycin biosynthesis, gene cluster for coding same |
06/27/2012 | CN102516373A Pneumococcal surface protein A without human homology, purification method and application thereof |
06/27/2012 | CN102516372A A mutated immunoglobulin-binding protein |
06/27/2012 | CN102516371A a mutated immunoglobulin-binding protein |
06/27/2012 | CN102516370A Anti-HIV (human immunodeficiency virus) medicine target and use thereof in pharmacy |
06/27/2012 | CN102516369A Mutant polyhedron and preparation method thereof |
06/27/2012 | CN102516354A Separation method and equipment of protein from starch sugar liquefied solution |
06/27/2012 | CN102516199A Compound and application thereof to sulfanilamide medicament detection |
06/27/2012 | CN102516148A Half antigen and antigen of tenuazonic acid and preparation method and application thereof |
06/27/2012 | CN102512670A Streptococcus pyogenes antigens |
06/27/2012 | CN102512662A Protein containing 36-83 amino acid motifs in Coxsackie B3virus 2B protein and application thereof |
06/27/2012 | CN102512661A Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same |
06/27/2012 | CN102512660A Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same |
06/27/2012 | CN102080079B Preparation method and application of novel antimicrobial peptide Misgurin mutant |
06/27/2012 | CN101928718B Protein trimerization modif and application thereof |
06/27/2012 | CN101921776B Brassica napus disease-resistance related gene BnERF56 and application thereof |
06/27/2012 | CN101921325B Antigen capable of increasing CD4 + CD25 + Foxp3 + regulatory T cells and application thereof |
06/27/2012 | CN101914545B Leucine-rich protein ALM gene of branchiostoma japonicum and application thereof |
06/27/2012 | CN101892244B Oryza officinalis anti-Xanthomonas oryzae major gene Xa3/Xa26-2 and application for improving disease resistance of rice thereof |
06/27/2012 | CN101863976B Preparation method of EV71 virus antibody |
06/27/2012 | CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody |
06/27/2012 | CN101830980B Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method |
06/27/2012 | CN101808668B Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
06/27/2012 | CN101736012B Stress resistance ERF transcription factor gene derived from Brassica napus |
06/27/2012 | CN101671678B Halimodendron halodendron DREB transcription factor cDNA sequence, expression carrier and application thereof |
06/27/2012 | CN101463086B Diethoxy thiophosphate organophosphorus pesticide antibody, and preparation and use thereof |
06/27/2012 | CN101450966B Polypeptide of antimicrobial agent and use |
06/27/2012 | CN101445554B Wood frog anticancer peptide and preparation method thereof |
06/27/2012 | CN101445552B Rice protein OsOEE3-1, encoding gene and application thereof |
06/27/2012 | CN101392232B Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine |
06/27/2012 | CN101374950B Improved IL-15 and IL-15R-alpha for expression in mammalian cells |
06/27/2012 | CN101294964B Reagent and method for detecting active tuberculosis and tuberculosis dormant infection |
06/27/2012 | CN101171262B Glucagon-like-peptide-2 (GLP-2) analogues |
06/27/2012 | CN101107268B Specific binding members for NGF |
06/27/2012 | CN101068935B Genes and polypeptides relating to breast cancers |
06/26/2012 | USRE43497 Anti-MIF antibodies |
06/26/2012 | US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
06/26/2012 | US8207322 Fluorescent protein and chromoprotein |
06/26/2012 | US8207315 Expression vector comprising nucleotide sequence coding angiogenic factor (VG5Q protein) for use in identifying modulators which reduce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activity and treat or prevent cell proliferative disorders |
06/26/2012 | US8207314 Tumor antigens for prevention and/or treatment of cancer |
06/26/2012 | US8207302 Maize cellulose synthases and uses thereof |
06/26/2012 | US8207301 Hepatocellular carcinoma protein marker |
06/26/2012 | US8207300 CTSP cancer-testis antigens |
06/26/2012 | US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof |
06/26/2012 | US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
06/26/2012 | US8207123 Tumour-specific animal proteins |
06/26/2012 | US8207122 Anti-cancer bioactive peptides isolated from crude venom of Xinjiang Lycosa singoriensis |
06/26/2012 | US8207119 Ophthalmological composition |
06/26/2012 | US8207117 Methods of reducing hemorrhage due to surgical procedure |
06/26/2012 | US8207114 Targeted therapeutic proteins |
06/26/2012 | US8207113 Methods for characterizing glycoproteins and generating antibodies for same |
06/26/2012 | US8207112 Liquid formulation of G-CSF conjugate |
06/26/2012 | US8206989 Method of generating a dosing schedule using gamma secretase notch biomarkers |
06/26/2012 | US8206948 Nucleotide sequences coding sialoglycoprotein-130 (Sgp 130) for use in prevention and treatment of crohn's disease |
06/26/2012 | US8206947 Human transmembrane proteins |
06/26/2012 | US8206938 In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors |
06/26/2012 | US8206937 Tumor suppressor gene p33ING2 |
06/26/2012 | US8206899 Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms |
06/26/2012 | US8206750 Charged lipoprotein complexes and their uses |
06/26/2012 | US8206743 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
06/26/2012 | US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics |
06/26/2012 | US8206719 KDR peptides and vaccines comprising the same |
06/26/2012 | US8206718 Expression and export of angiogenesis inhibitors as immunofusins |
06/26/2012 | US8206713 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2 |
06/26/2012 | US8206708 Vascular endothelial growth factor 2 |
06/26/2012 | US8206706 Method for enhancing or inhibiting insulin-like growth factor-I |
06/26/2012 | US8206693 PMMA binding peptides |
06/26/2012 | CA2735129C Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
06/26/2012 | CA2605629C Nipah virus vaccines |
06/26/2012 | CA2526950C Method for determining immune system affecting compounds |
06/26/2012 | CA2484594C Process for the synthesis of peptides |
06/26/2012 | CA2462615C Promoters for regulation of gene expression in plant roots |
06/26/2012 | CA2452716C Mammalian sweet and amino acid heterodimeric taste receptors |
06/26/2012 | CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes |
06/26/2012 | CA2426952C Small molecule compositions for binding to hsp90 |
06/26/2012 | CA2406225C Recombinant intracellular pathogen vaccines and methods for use |
06/26/2012 | CA2405537C Vaccine comprising a tick cement protein |
06/26/2012 | CA2343980C Mammaglobin, a secreted mammary-specific breast cancer protein |
06/26/2012 | CA2323785C Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments |
06/26/2012 | CA2270448C Method for giving resistance to weed control compounds to plants |
06/26/2012 | CA2263895C Therapeutic and diagnostic applications of perlecan domain i splice variants |
06/21/2012 | WO2012083297A2 Adenoviral vectors with modified hexon regions |
06/21/2012 | WO2012083219A1 Combined use of vip3ab and cry1ab for management of resistance insects |
06/21/2012 | WO2012083099A1 Biologically-active radiolabeled cry1fa and receptor binding assay methods |
06/21/2012 | WO2012082933A1 Eluate collection using conductivity gradient |
06/21/2012 | WO2012082891A1 Synthetic peptide inhibitors of wnt pathway |
06/21/2012 | WO2012082325A1 Cry1i proteins and genes for insect control |
06/21/2012 | WO2012082056A1 Novel biomarker and uses thereof in diagnosis, treatment of autism |
06/21/2012 | WO2012081711A1 Cell migration modulator |
06/21/2012 | WO2012081306A1 Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria |
06/21/2012 | WO2012081040A1 Biological activity of placental protein 13 |
06/21/2012 | WO2012080844A1 Cell culture medium |
06/21/2012 | WO2012080842A1 Recombinant laminin-521 |
06/21/2012 | WO2012080551A1 Cloneable marker for use in microscopy |
06/21/2012 | WO2012080548A1 Bak mutant, associated method for the identification of bak-modulating substances and bak activity inhibiting peptide |
06/21/2012 | WO2012080516A2 Malodour standards and inhibitors |
06/21/2012 | WO2012080510A1 Paralysation of silkworm larvae |
06/21/2012 | WO2012080500A1 Serum amyloid p protein |
06/21/2012 | WO2012080422A1 Method for separating, concentrating or purifying a (blood) plasma protein or viral component from a mixture |
06/21/2012 | WO2012079979A1 Aqueous factor viii solution |